2. Subjects currently have a clinically significant neurological, metabolic (including type I diabetes), hepatic, renal, hematological, pulmonary, cardiovascular, gastrointestinal and/or urological disorder. Subjects with human immunodeficiency virus (HIV) seropositivity (or history of seropositivity) will be excluded.